Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study
Titel:
Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study
Auteur:
Ishida, Masaki Morimoto, Kenji Yamada, Tadaaki Takeda, Takayuki Shiotsu, Shinsuke Date, Koji Harada, Taishi Tamiya, Nobuyo Chihara, Yusuke Takemura, Yoshizumi Yamada, Takahiro Kanda, Hibiki Iwasaku, Masahiro Tokuda, Shinsaku Kim, Young Hak Takayama, Koichi